DBMYX
Price
$27.24
Change
-$0.13 (-0.47%)
Updated
Sep 20 closing price
RPMGX
Price
$109.07
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

DBMYX vs RPMGX

Header iconDBMYX vs RPMGX Comparison
Open Charts DBMYX vs RPMGXBanner chart's image
BNY Mellon Sm/Md Cp Gr Y
Price$27.24
Change-$0.13 (-0.47%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth
Price$109.07
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DBMYX vs RPMGX Comparison Chart
Loading...
VS
DBMYX vs. RPMGX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBMYX is a Buy and RPMGX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPMGX has more cash in the bank: 31.4B vs. DBMYX (1.29B). RPMGX pays higher dividends than DBMYX: RPMGX (0.05) vs DBMYX (0.00). DBMYX was incepted earlier than RPMGX: DBMYX (11 years) vs RPMGX (32 years). DBMYX is a more actively managed with annual turnover of: 36.02 vs. RPMGX (21.70). RPMGX has a lower initial minimum investment than DBMYX: RPMGX (2500) vs DBMYX (1000000). DBMYX annual gain was more profitable for investors over the last year : 17.11 vs. RPMGX (14.65). DBMYX return over 5 years is better than : 19.26 vs. RPMGX (14.51).
DBMYXRPMGXDBMYX / RPMGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years32 years-
Gain YTD2.2919.02625%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.29B31.4B4%
Annual Yield % from dividends0.000.05-
Returns for 1 year17.1114.65117%
Returns for 3 years-32.62-13.81236%
Returns for 5 years19.2614.51133%
Returns for 10 years49.8343.29115%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CEAD6.90-0.10
-1.43%
CEA Industries
ELF112.91-1.68
-1.47%
elf Beauty
WAFD35.21-1.20
-3.30%
WaFd
PKST15.04-0.67
-4.26%
Peakstone Realty Trust
CHRS1.02-0.11
-9.73%
Coherus BioSciences